Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Jadelle
Active Ingredient: Levonorgestrel 75mg
Dosage Form: Subcutaneous implant
New Zealand Sponsor: Schering (NZ) Limited
Manufacturer: Schering Oy, Turku 10, Finland
Product: Nicotinell (Fruit flavoured)
Active Ingredient: Nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: Nicotinell (Fruit flavoured)
Active Ingredient: Nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacture: Fertin Pharma A/S, Vejle, Denmark
Product: Nicotinell (Liquorice flavoured)
Active Ingredient: Nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: Nicotinell (Liquorice flavoured)
Active Ingredient: Nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: Nicotinell (Mint flavoured)
Active Ingredient: Nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: Nicotinell (Mint flavoured)
Active Ingredient: Nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Dated this 5th day of August 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).